Meprolen

Omeprazole, the active ingredient in Meprolen, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, peptic ulcer disease and erosive esophagitis.

GNH USA supplies Meprolen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric proton pump to manage acid‑related conditions.

Gastro‑oesophageal reflux disease: provides symptomatic relief and promotes healing of esophageal erosion. Peptic ulcer disease: accelerates ulcer healing and lowers recurrence risk. Erosive esophagitis: speeds mucosal recovery and prevents further damage. Helicobacter pylori eradication regimen: used as part of combination therapy to improve eradication rates.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Diarrhea: loose stools may occur. - Nausea: feeling of queasiness. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Clostridioides difficile infection: risk of severe colitis. - Hypomagnesemia: low magnesium levels with prolonged use. - Elevated liver enzymes: possible hepatic involvement. - Interstitial nephritis: inflammation of kidney tissue. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor magnesium: long‑term treatment may cause hypomagnesemia. - Evaluate CYP2C19 status: genetic variations can affect drug levels. - Use cautiously in the elderly: higher risk of fractures and infections. - Avoid abrupt discontinuation: may lead to rebound acid hypersecretion. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Omeprazole can interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Ketoconazole: lowered antifungal activity. - Warfarin: unpredictable INR changes.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentration. - Methotrexate: heightened toxicity risk. - Phenytoin: reduced plasma levels. - Calcium carbonate: may affect omeprazole absorption. - Iron salts: can diminish omeprazole effectiveness.